[
  {
    "date": "2023-12-30",
    "symbol": "OVID",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-38085",
    "entityregistrantname": "Ovid Therapeutics Inc.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "46-5270895",
    "entityaddressaddressline1": "441 Ninth Avenue",
    "entityaddressaddressline2": "14th Floor",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10001,
    "cityareacode": 646,
    "localphonenumber": "661-7661",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "OVID",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "amendmentflag": "false",
    "entitycentralindexkey": 1636651,
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "auditorfirmid": 185,
    "auditorname": "KPMG LLP",
    "auditorlocation": "New York, New York",
    "cashandcashequivalentsatcarryingvalue": 27041517,
    "availableforsalesecuritiesdebtsecuritiescurrent": 78791858,
    "prepaidexpenseandotherassetscurrent": 3764332,
    "assetscurrent": 109597707,
    "longterminvestments": 17625620,
    "restrictedcash": 1930753,
    "operatingleaserightofuseasset": 13894376,
    "propertyplantandequipmentnet": 768753,
    "otherassetsnoncurrent": 209574,
    "assets": 144026783,
    "accountspayablecurrent": 3702936,
    "accruedliabilitiescurrent": 6525235,
    "operatingleaseliabilitycurrent": 1246119,
    "liabilitiescurrent": 11474290,
    "operatingleaseliabilitynoncurrent": 14755606,
    "royaltymonetizationliabilitynoncurrent": 30000000,
    "liabilities": 56229896,
    "preferredstockvalue": 1,
    "commonstockvalue": 70692,
    "additionalpaidincapital": 365590993,
    "accumulatedothercomprehensiveincomelossnetoftax": 702,
    "retainedearningsaccumulateddeficit": -277865501,
    "stockholdersequity": 87796887,
    "liabilitiesandstockholdersequity": 144026783,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "preferredstocksharedesignated": 10000,
    "preferredstocksharesissued": 1250,
    "preferredstocksharesoutstanding": 1250,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 125000000,
    "commonstocksharesissued": 70691992,
    "commonstocksharesoutstanding": 70691992,
    "revenuefromcontractwithcustomerexcludingassessedtax": 391695,
    "researchanddevelopmentexpense": 28587884,
    "generalandadministrativeexpense": 31085274,
    "operatingexpenses": 59673158,
    "operatingincomeloss": -59281464,
    "othernonoperatingincomeexpense": 6942505,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -52338959,
    "netincomeloss": -52338959,
    "earningspersharebasic": -0.74,
    "earningspersharediluted": -0.74,
    "weightedaveragenumberofsharesoutstandingbasic": 70580604,
    "weightedaveragenumberofdilutedsharesoutstanding": 70580604,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 702,
    "comprehensiveincomenetoftax": -52338257,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 225107,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 225,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 7285192,
    "othercomprehensiveincomelossbeforetaxportionattributabletoparent": 42889,
    "equitysecuritiesfvniunrealizedgainloss": 2003073,
    "changeinaccruedinterestandaccretionofdiscountsshortterminvestments": -2172254,
    "sharebasedcompensation": 7285192,
    "depreciationdepletionandamortization": 568282,
    "operatingleaserightofuseassetamortizationexpense": 1028293,
    "increasedecreaseinoperatingleaseliability": -533946,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1385052,
    "increasedecreaseinaccountspayabletrade": 1750026,
    "increasedecreaseinaccruedliabilities": 2020566,
    "netcashprovidedbyusedinoperatingactivities": -45780925,
    "paymentstoacquireavailableforsalesecuritiesdebt": 112443150,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 120000000,
    "paymentstoacquirelongterminvestments": 10000000,
    "paymentstoacquirepropertyplantandequipment": 40308,
    "paymentstodevelopsoftware": 97147,
    "netcashprovidedbyusedininvestingactivities": -2580605,
    "proceedsfromstockoptionsexercised": 535201,
    "proceedsfromroyaltiesreceivedfinancingactivities": 30000000,
    "netcashprovidedbyusedinfinancingactivities": 30535201,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -17826329,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 28972270,
    "rightofuseassetandleaseliabilitiesoperatingleasetabletextblock": "ROU asset and lease liabilities related to the Company's operating lease are as follows:December 31,2023December 31,2022ROU asset$13,894,376 $14,922,669 Current lease liability$1,246,119 $533,946 Long-term lease liability$14,755,606 $16,001,725",
    "cashcashequivalentsandshortterminvestments": 105800000,
    "workingcapital": 98100000,
    "unrealizedgainlossoninvestments": 1200000,
    "equitymethodinvestments": 1300000,
    "assetsfairvaluedisclosure": 25700000,
    "propertyplantandequipmentusefullife": "P3Y",
    "investmentinterestrate": 0.13,
    "ownershipinterestrate": 1,
    "definedcontributionplanname": "401(k)-retirement plan",
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 1,
    "definedcontributionplanemployermatchingcontributionpercent": 0.03,
    "definedcontributionplanemployerdiscretionarycontributionamount": 311640,
    "cash": 2701396,
    "cashequivalentsamortizedcost": 24340121,
    "cashequivalentsatcarryingvalue": 24340121,
    "availableforsaledebtsecuritiesamortizedcostbasis": 78791156,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 702,
    "availableforsalesecuritiesdebtsecurities": 78791858,
    "cashcashequivalentsandavailableforsaledebtsecuritiesamortizedcost": 105832673,
    "debtsecuritiesavailableforsaleaccumulatedgrossunrealizedgainbeforetaxincludingcashequivalentsaccumulatedunrealizedholdinggain": 702,
    "propertyplantandequipmentgross": 1463340,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1000899,
    "depreciation": 419518,
    "finitelivedintangibleassetsnet": 182974,
    "amortizationofintangibleassets": 148764,
    "paymentsforrent": 2300000,
    "lesseeoperatingleaseremainingleaseterm": "P9Y",
    "lesseeoperatingleaserenewalterm": "P5Y",
    "leaseincrementalborrowingrate": 0.0702,
    "operatingleasecost": 2167233,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2316303,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2316303,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 2316303,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 2316303,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 2469447,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 9877788,
    "lesseeoperatingleaseliabilitypaymentsdue": 21612447,
    "employeerelatedliabilitiescurrent": 4277034,
    "accruedresearchanddevelopment": 1395751,
    "accruedprofessionalfeescurrent": 521942,
    "otheraccruedliabilitiescurrent": 330508,
    "commonstocknumberofvotesforeachshare": 1,
    "convertiblepreferredstocksharesissueduponconversion": 1000,
    "maximumallowableowningpercentageofoutstandingcommonstockbyassociatesoraffiliates": 0.0999,
    "maximumallowablevotingrightpercentageofoutstandingcommonstockholders": 0.1499,
    "allowableowningpercentageofoutstandingcommonstockbyassociatesoraffiliates": 0.1999,
    "allowableowningpercentageofoutstandingcommonstockbyassociatesoraffiliatesnoticeperiod": "P61D",
    "beneficialownershiplimitationspercentageofissuedandoutstandingcommonstock": 0.1,
    "preferredstockliquidationpreference": 0.001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 4400759,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpricepurchasedate": 0.15,
    "allocatedsharebasedcompensationexpense": 57148,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 98542,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximumincrease": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorizedmaximum": 550000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 9300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P90D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 45000000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharespurchasedforaward": 63761,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y2M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8452,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y25D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0397,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 15124546,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 9649094,
    "stockissuedduringperiodsharesstockoptionsexercised": 146346,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 728346,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 4.47,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.63,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 3.44,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P5Y11M19D",
    "sharebasedcompensationbysharebasedpaymentawardoptionsgrantedcontractuallife": "P9Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 5212586,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 2464620,
    "operatinglosscarryforwards": 150200000,
    "valuationallowancedeferredtaxassetchangeinamount": 18900000,
    "deferredtaxassetsoperatinglosscarryforwards": 55653286,
    "deferredtaxassetsgoodwillandintangibleassets": 7522067,
    "deferredtaxassetscapitalizedresearchanddevelopmentcosts": 10909248,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 7248199,
    "deferredtaxassetsroyaltymonetizationliability": 8427970,
    "deferredtaxassetstaxdeferredexpenseleaseliability": 4495402,
    "deferredtaxassetsdeferredexpenseresearchanddevelopmenttaxcredits": 2877649,
    "deferredtaxliabilitiespropertyplantandequipment": 166075,
    "deferredtaxliabilitiesleasingarrangements": 3903379,
    "deferredtaxliabilitiesother": -434957,
    "deferredtaxassetsgross": 92629410,
    "deferredtaxassetsvaluationallowance": 92629410,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0912,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.0132,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.2923,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.0105,
    "effectiveincometaxratereconciliationotheradjustments": -0.0062,
    "licenseagreementmilestonepayments": 30000000,
    "licenseagreementterminationadvancenoticeperiod": "P90D",
    "contingenciesseverancepaymentsandbenefitseligibilityfollowingterminationperiod": "P2Y",
    "percentageofpotentialroyalties": 0.13,
    "percentageofdevelopmentcosts": 0.5,
    "equitysecuritiesfvniunrealizedloss": 800000,
    "netincomelossavailabletocommonstockholdersbasic": -52338959,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 15124546
  },
  {
    "date": "2022-12-30",
    "symbol": "OVID",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2022-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-38085",
    "entityregistrantname": "Ovid Therapeutics Inc.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "46-5270895",
    "entityaddressaddressline1": "441 Ninth Avenue",
    "entityaddressaddressline2": "14th Floor",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10001,
    "cityareacode": 646,
    "localphonenumber": "661-7661",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "OVID",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "amendmentflag": "false",
    "entitycentralindexkey": 1636651,
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "auditorfirmid": 185,
    "auditorname": "KPMG LLP",
    "auditorlocation": "New York, New York",
    "cashandcashequivalentsatcarryingvalue": 44867846,
    "availableforsalesecuritiesdebtsecuritiescurrent": 84133565,
    "prepaidexpenseandotherassetscurrent": 2379280,
    "assetscurrent": 131380691,
    "longterminvestments": 5622547,
    "restrictedcash": 1930753,
    "operatingleaserightofuseasset": 14922669,
    "propertyplantandequipmentnet": 1147963,
    "otherassetsnoncurrent": 261191,
    "assets": 155265814,
    "accountspayablecurrent": 1952910,
    "accruedliabilitiescurrent": 4504669,
    "operatingleaseliabilitycurrent": 533946,
    "liabilitiescurrent": 6991525,
    "operatingleaseliabilitynoncurrent": 16001725,
    "liabilities": 22993250,
    "preferredstockvalue": 1,
    "commonstockvalue": 70467,
    "additionalpaidincapital": 357770825,
    "accumulatedothercomprehensiveincomelossnetoftax": -42187,
    "retainedearningsaccumulateddeficit": -225526542,
    "stockholdersequity": 132272564,
    "liabilitiesandstockholdersequity": 155265814,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "preferredstocksharedesignated": 10000,
    "preferredstocksharesissued": 1250,
    "preferredstocksharesoutstanding": 1250,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 125000000,
    "commonstocksharesissued": 70466885,
    "commonstocksharesoutstanding": 70466885,
    "revenuefromcontractwithcustomerexcludingassessedtax": 1502748,
    "researchanddevelopmentexpense": 24618399,
    "generalandadministrativeexpense": 32432510,
    "operatingexpenses": 57050909,
    "operatingincomeloss": -55548161,
    "othernonoperatingincomeexpense": 1379132,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -54169029,
    "netincomeloss": -54169029,
    "earningspersharebasic": -0.77,
    "earningspersharediluted": -0.77,
    "weightedaveragenumberofsharesoutstandingbasic": 70424819,
    "weightedaveragenumberofdilutedsharesoutstanding": 70424819,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -42187,
    "comprehensiveincomenetoftax": -54211216,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 101973,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 108,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 6556686,
    "othercomprehensiveincomelossbeforetaxportionattributabletoparent": -42187,
    "noncashconsiderationreceivedinlicensingagreementtransaction": 945366,
    "equitysecuritiesfvniunrealizedgainloss": -454811,
    "interestincomeandaccretionofdiscountsshortterminvestments": -1211311,
    "sharebasedcompensation": 6556686,
    "depreciationdepletionandamortization": 512505,
    "operatingleaserightofuseassetamortizationexpense": 869100,
    "accretionofleaseliability": 936927,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -109292,
    "increasedecreaseinaccountspayabletrade": -5174136,
    "increasedecreaseinaccruedliabilities": -3166606,
    "netcashprovidedbyusedinoperatingactivities": -55227127,
    "paymentstoacquireavailableforsalesecuritiesdebt": 172964441,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 90000000,
    "paymentstoacquirelongterminvestments": 2500000,
    "paymentsforproceedsfromissuanceofshorttermnotereceivable": 1000000,
    "paymentstoacquirepropertyplantandequipment": 1224379,
    "paymentstodevelopsoftware": 194397,
    "netcashprovidedbyusedininvestingactivities": -87883217,
    "proceedsfromstockoptionsexercised": 180658,
    "netcashprovidedbyusedinfinancingactivities": 180658,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -142929686,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 46798599,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 15791769,
    "conversionofshorttermnotereceivabletolongtermequityinvestment": 1000000,
    "cashcashequivalentsandshortterminvestments": 129000000,
    "workingcapital": 124400000,
    "equitymethodinvestments": 5100000,
    "assetsfairvaluedisclosure": 42500000,
    "availableforsalesecuritiesdebtsecurities": 84100000,
    "propertyplantandequipmentusefullife": "P3Y",
    "definedcontributionplanname": "401(k)-retirement plan",
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 1,
    "definedcontributionplanemployermatchingcontributionpercent": 0.03,
    "definedcontributionplanemployerdiscretionarycontributionamount": 339405,
    "cashequivalentsatcarryingvalue": 2853042,
    "cashandcashequivalentsfairvaluedisclosure": 2853042,
    "availableforsaledebtsecuritiesamortizedcostbasis": 84175752,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 42187,
    "cashcashequivalentsandavailableforsaledebtsecuritiesamortizedcost": 129043599,
    "propertyplantandequipmentgross": 1423032,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 581381,
    "depreciation": 319173,
    "finitelivedintangibleassetsnet": 222100,
    "amortizationofintangibleassets": 193333,
    "paymentsforrent": 2300000,
    "lesseeoperatingleaseremainingleaseterm": "P10Y",
    "lesseeoperatingleaserenewalterm": "P5Y",
    "leaseincrementalborrowingrate": 0.0702,
    "operatingleasecost": 1806028,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1672886,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2316303,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 2316303,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 2316303,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 2316303,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 12347235,
    "lesseeoperatingleaseliabilitypaymentsdue": 23285333,
    "employeerelatedliabilitiescurrent": 3233802,
    "accruedresearchanddevelopment": 395247,
    "accruedprofessionalfeescurrent": 682664,
    "otheraccruedliabilitiescurrent": 192956,
    "commonstocknumberofvotesforeachshare": 1,
    "convertiblepreferredstocksharesissueduponconversion": 1000,
    "maximumallowableowningpercentageofoutstandingcommonstockbyassociatesoraffiliates": 0.0999,
    "maximumallowablevotingrightpercentageofoutstandingcommonstockholders": 0.1499,
    "allowableowningpercentageofoutstandingcommonstockbyassociatesoraffiliates": 0.1999,
    "allowableowningpercentageofoutstandingcommonstockbyassociatesoraffiliatesnoticeperiod": "P61D",
    "beneficialownershiplimitationspercentageofissuedandoutstandingcommonstock": 0.1,
    "preferredstockliquidationpreference": 0.001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 3052059,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorized": 3187069,
    "commonstockcapitalsharesreservedforfutureissuance": 279069,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpricepurchasedate": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharespurchasedforaward": 76455,
    "allocatedsharebasedcompensationexpense": 85319,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximumincrease": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorizedmaximum": 550000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P90D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 4575641,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 127459,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 626977,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y3M3D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8716,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y25D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0221,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.12,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 12961238,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 6742890,
    "stockissuedduringperiodsharesstockoptionsexercised": 25518,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 2365643,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.13,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 5.05,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.89,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.91,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 5.56,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y5M1D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P6Y2M12D",
    "sharebasedcompensationbysharebasedpaymentawardoptionsgrantedcontractuallife": "P9Y3M3D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 62158,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 61214,
    "operatinglosscarryforwards": 153500000,
    "valuationallowancedeferredtaxassetchangeinamount": 10400000,
    "deferredtaxassetsoperatinglosscarryforwards": 55472573,
    "deferredtaxassetsgoodwillandintangibleassets": 6332176,
    "deferredtaxassetscapitalizedresearchanddevelopmentcosts": 4246071,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 4384751,
    "deferredtaxassetstaxdeferredexpenseleaseliability": 3544624,
    "deferredtaxassetsdeferredexpenseresearchanddevelopmenttaxcredits": 3046253,
    "deferredtaxliabilitiespropertyplantandequipment": 241096,
    "deferredtaxliabilitiesleasingarrangements": 3198857,
    "deferredtaxassetstaxdeferredexpenseother": 97494,
    "deferredtaxassetsgross": 73683989,
    "deferredtaxassetsvaluationallowance": 73683989,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.0027,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.0126,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.185,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.0128,
    "effectiveincometaxratereconciliationotheradjustments": -0.0225,
    "potentialfundingcostpercent": 0.35,
    "costofagreementnet": 7000000,
    "deferredupfrontpaymentcosts": 7000000,
    "additionalupfrontfeeamount": 5000000,
    "upfrontfeeamount": 20000000,
    "equitymethodinvestmentownershippercentage": 0.5,
    "percentageofdevelopmentcosts": 0.5,
    "equitysecuritiesfvniunrealizedloss": 500000,
    "netincomelossavailabletocommonstockholdersbasic": -54169029,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 12961238
  },
  {
    "date": "2021-12-30",
    "symbol": "OVID",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Ovid Therapeutics Inc.",
    "entitycentralindexkey": 1636651,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": " No",
    "entityfilercategory": "Non-accelerated Filer",
    "entityinteractivedatacurrent": "Yes",
    "entityextransitionperiod": "true",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "true",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "OVID",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "entityfilenumber": "001-38085",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "46-5270895",
    "entityaddressaddressline1": "1460 Broadway",
    "entityaddressaddressline2": "Suite 15021",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "New York",
    "entityaddresspostalzipcode": 10036,
    "cityareacode": 646,
    "localphonenumber": "661-7661",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "KPMG LLP",
    "auditorlocation": "New York, New York",
    "auditorfirmid": 185,
    "cashandcashequivalentsatcarryingvalue": "null",
    "prepaidexpenseandotherassetscurrent": "null",
    "assetscurrent": "null",
    "longterminvestments": "null",
    "restrictedcash": 1.9,
    "securitydeposit": 96034,
    "propertyplantandequipmentnet": 242757,
    "otherassetsnoncurrent": 164092,
    "assets": "null",
    "accountspayablecurrent": "null",
    "accruedliabilitiescurrent": "null",
    "liabilitiescurrent": "null",
    "liabilities": "null",
    "preferredstockvalue": 1,
    "commonstockvalue": 70359,
    "additionalpaidincapitalcommonstock": "null",
    "retainedearningsaccumulateddeficit": "-null",
    "stockholdersequity": "-null",
    "liabilitiesandstockholdersequity": "null",
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "preferredstocksharedesignated": 10000,
    "preferredstocksharesissued": 1250,
    "preferredstocksharesoutstanding": 1250,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerincludingassessedtax": 12400000,
    "researchanddevelopmentexpense": 2.5,
    "generalandadministrativeexpense": 100000,
    "operatingexpenses": "null",
    "operatingincomeloss": "null",
    "otheroperatingincomeexpensenet": -45690,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": "null",
    "incometaxexpensebenefit": 1300000,
    "netincomeloss": "null",
    "earningspersharebasic": 1.78,
    "earningspersharediluted": 1.76,
    "netincomelossavailabletocommonstockholdersbasic": "null",
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "comprehensiveincomenetoftax": "null",
    "sharesissued": "null",
    "stockissuedduringperiodvaluepurchaseofassets": "null",
    "stockissuedduringperiodsharespurchaseofassets": "null",
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 118265,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 60490,
    "stockissuedduringperiodvaluestockoptionsexercised": 807474,
    "stockissuedduringperiodsharesstockoptionsexercised": 288525,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": -1998,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": "null",
    "noncashresearchanddevelopmentexpense": "null",
    "sharebasedcompensation": "null",
    "depreciationdepletionandamortization": 237079,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -14089,
    "increasedecreaseinsecuritydeposits": 54592,
    "increasedecreaseduefromaffiliates": 141763,
    "increasedecreaseinprepaidexpensenoncurrent": 477171,
    "increasedecreaseinaccountspayabletrade": "null",
    "increasedecreaseinaccruedliabilities": "-null",
    "increasedecreaseindeferredrevenue": "-null",
    "increasedecreaseinduetorelatedparties": "-null",
    "netcashprovidedbyusedinoperatingactivities": "null",
    "paymentstoacquireequitymethodinvestments": "null",
    "paymentstoacquirepropertyplantandequipment": 184008,
    "paymentstodevelopsoftware": 5400,
    "netcashprovidedbyusedininvestingactivities": "-null",
    "paymentsofstockissuancecosts": 21314,
    "proceedsfromstockplans": 118205,
    "proceedsfromstockoptionsexercised": 807191,
    "netcashprovidedbyusedinfinancingactivities": 904082,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": "null",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": "null",
    "workingcapital": 175700000,
    "descriptionofownershippatternasperlicenseandcollaborationagreement": "the Company and Takeda were equally sharing in the costs of development for soticlestat",
    "cashfdicinsuredamount": 250000,
    "availableforsalesecuritiesinvestmentsmaturityperiod": "three months",
    "equitymethodinvestments": 1600000,
    "propertyplantandequipmentestimatedusefullives": "Property and equipment are stated at cost and depreciated over their estimated useful lives of three years using the straight-line method.",
    "propertyplantandequipmentusefullife": "three years",
    "assetsfairvaluedisclosure": 187600000,
    "definedcontributionplanname": "401(k)-retirement plan",
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.5,
    "definedcontributionplanemployermatchingcontributionpercent": 0.05,
    "definedcontributionplanemployerdiscretionarycontributionamount": 438000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1250,
    "cashequivalentsatcarryingvalue": "null",
    "cashandcashequivalentsfairvaluedisclosure": "null",
    "propertyplantandequipmentgross": 504965,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 262208,
    "depreciation": 77000,
    "finitelivedintangibleassetsnet": 164000,
    "amortizationofintangibleassets": 160000,
    "clinicaltrialsaccrualcurrent": "null",
    "employeerelatedliabilitiescurrent": "null",
    "accruedprofessionalfeescurrent": "null",
    "otheraccruedliabilitiescurrent": 546464,
    "commonstockvotingrights": "one vote for each share held",
    "convertiblepreferredstocksharesissueduponconversion": 1000,
    "maximumallowableowningpercentageofoutstandingcommonstockbyassociatesoraffiliates": 0.0999,
    "maximumallowablevotingrightpercentageofoutstandingcommonstockholders": 0.1499,
    "convertiblepreferredstocktermsofconversion": "percentage may be changed at the holder’s election to any other number less than or equal to 19.99% upon 61 days’ notice to the Company; provided, however, that effective 61 days after delivery of such notice, such beneficial ownership limitations shall not be applicable to any holder that beneficially owns either 10.0% or 15.0%",
    "preferredstockliquidationpreference": 0.001,
    "dividendpaymentrestrictionsscheduledescription": "No dividends on the common stock shall be declared and paid unless dividends on the Preferred Stock have been declared and paid.",
    "commonstockcapitalsharesreservedforfutureissuance": 279069,
    "sharebasedcompensationarrangementbysharebasedpaymentawardplanmodificationdescriptionandterms": "The number of shares of common stock reserved for issuance under the 2017 ESPP will automatically increase on January 1 of each year, beginning on January 1, 2018 and continuing through and including January 1, 2027, by the lesser of (i) 1% of the total number of shares of the Company’s capital stock outstanding on December 31 of the preceding calendar year, (ii) 550,000 shares or (iii) such lesser number of shares determined by our Board.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 493062,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpricepurchasedate": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharespurchasedforaward": 60490,
    "allocatedsharebasedcompensationexpense": 83787,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumnumberofsharesperemployee": 550000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten-year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four-year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 90,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 10.4,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 150000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8043000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0103,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.97,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 5.98,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.53,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.36,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 4.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 6.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 4.63,
    "sharebasedcompensationbysharebasedpaymentawardoptionsgrantedcontractuallife": 9.47,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": "null",
    "operatinglosscarryforwards": 163900000,
    "operatinglosscarryforwardsexpirationperiodstart": 2035,
    "valuationallowancedeferredtaxassetchangeinamount": 26500000,
    "ownershippercentagedescription": "if a corporation undergoes an ownership change (generally defined as a greater than 50% change in its equity ownership over a three-year period), the corporation’s ability to use its pre-change NOL carryforwards and other pre-change tax attributes to offset its post-change income may be limited.",
    "greaterthanchangeinequityownershippercentage": 0.5,
    "deferredtaxassetsoperatinglosscarryforwards": "null",
    "deferredtaxassetstaxcreditcarryforwardsresearch": "null",
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": "null",
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitsemployeecompensation": 28243,
    "deferredtaxliabilitiespropertyplantandequipment": 51920,
    "deferredtaxassetscharitablecontributioncarryforwards": 87672,
    "deferredtaxassetsgoodwillandintangibleassets": "null",
    "deferredtaxassetsgross": "null",
    "deferredtaxassetsvaluationallowance": "null",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0105,
    "effectiveincometaxratereconciliationnondeductibleexpense": 0.0053,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.2139,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.0105,
    "effectiveincometaxratereconciliationotheradjustments": 0.009300000000000001,
    "effectiveincometaxratecontinuingoperations": 0.010700000000000001,
    "licenseagreementupfrontpayment": 20000000,
    "additionalupfrontfeeamount": 5000000,
    "potentialfundingcostpercent": 0.35000000000000003,
    "costofagreementnet": 7000000,
    "deferredupfrontpaymentcosts": 7000000,
    "upfrontfeeamount": 196000000,
    "amountforpotentialfuturetrials": 7000000,
    "licenserevenue": 5400000,
    "agreementclosingdate": "March 2021",
    "equitymethodinvestmentownershippercentage": 0.5,
    "generalandadministrativeexpensereimbursementreceived": 2400000,
    "undistributedearningslossallocatedtoparticipatingsecuritiesbasic": "null"
  },
  {
    "date": "2020-12-30",
    "symbol": "OVID",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Ovid Therapeutics Inc.",
    "entitycentralindexkey": 1636651,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entityinteractivedatacurrent": "Yes",
    "entityextransitionperiod": "true",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "OVID",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-38085",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "46-5270895",
    "entityaddressaddressline1": "1460 Broadway",
    "entityaddressaddressline2": "Suite 15021",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10036,
    "cityareacode": 646,
    "localphonenumber": "661-7661",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 72033930,
    "accountsreceivablerelatedparties": 100000,
    "prepaidexpenseandotherassetscurrent": 2667508,
    "assetscurrent": 74843201,
    "prepaidexpensenoncurrent": 477171,
    "securitydeposit": 150626,
    "propertyplantandequipmentnet": 135620,
    "otherassetsnoncurrent": 318900,
    "assets": 75925518,
    "accountspayablecurrent": 5446206,
    "accruedliabilitiescurrent": 12032685,
    "duetorelatedpartiescurrent": 2370992,
    "deferredrevenuecurrent": 2212892,
    "liabilitiescurrent": 22062775,
    "duetorelatedpartiesnoncurrent": 61200,
    "deferredrevenuenoncurrent": 10169887,
    "liabilities": 32293862,
    "preferredstockvalue": 3,
    "commonstockvalue": 65743,
    "additionalpaidincapitalcommonstock": 337758007,
    "retainedearningsaccumulateddeficit": -294192097,
    "stockholdersequity": -294192097,
    "liabilitiesandstockholdersequity": 75925518,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "preferredstocksharedesignated": 10000,
    "preferredstocksharesissued": 3250,
    "preferredstocksharesoutstanding": 3250,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 125000000,
    "commonstocksharesissued": 65743170,
    "commonstocksharesoutstanding": 65743170,
    "revenuefromcontractwithcustomerincludingassessedtax": 12600000,
    "typeofrevenueextensiblelist": "us-gaap:LicenseMember",
    "researchanddevelopmentexpense": 700000,
    "generalandadministrativeexpense": 30630804,
    "operatingexpenses": 94048198,
    "operatingincomeloss": -81430977,
    "otheroperatingincomeexpensenet": 395401,
    "netincomeloss": -81035576,
    "netincomelossavailabletocommonstockholdersbasic": -81035576,
    "earningspersharebasicanddiluted": -1.39,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 58451293,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -2469,
    "comprehensiveincomenetoftax": -81038045,
    "sharesissued": 65743170,
    "atmofferingcosts": -114936,
    "stockissuedduringperiodvaluestockoptionsexercised": 300821,
    "stockissuedduringperiodsharesstockoptionsexercised": 165384,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 203466,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 105464,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": -4507,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 2256,
    "stockissuedduringperiodvaluenewissues": 46731435,
    "stockissuedduringperiodsharesnewissues": 2256000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 7525354,
    "othercomprehensiveincomelossnetoftax": -2469,
    "sharebasedcompensation": 7525354,
    "depreciationdepletionandamortization": 306848,
    "accruedinterestandaccretionofdiscountsshortterminvestments": -199408,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 724575,
    "increasedecreaseinsecuritydeposits": -15236,
    "increasedecreaseduefromaffiliates": -989383,
    "increasedecreaseinprepaidexpensenoncurrent": 117632,
    "increasedecreaseinaccountspayabletrade": 2333716,
    "increasedecreaseinaccruedliabilities": 4835607,
    "increasedecreaseindeferredrevenue": 12382779,
    "increasedecreaseinduetorelatedparties": 2134826,
    "netcashprovidedbyusedinoperatingactivities": -51583914,
    "paymentstoacquireavailableforsalesecuritiesdebt": 9961092,
    "proceedsfrommaturitiesprepaymentsandcallsofavailableforsalesecurities": 45000000,
    "paymentstoacquirepropertyplantandequipment": 127240,
    "paymentstodevelopsoftware": 263440,
    "netcashprovidedbyusedininvestingactivities": 34648228,
    "proceedsfromissuanceofcommonstock": 46731435,
    "paymentsofstockissuancecosts": 163250,
    "proceedsfromstockplans": 203466,
    "proceedsfromstockoptionsexercised": 300821,
    "netcashprovidedbyusedinfinancingactivities": 47072472,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 30136786,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 72033930,
    "noninterestexpenseofferingcost": 21314,
    "workingcapital": 52800000,
    "descriptionofownershippatternasperlicenseandcollaborationagreement": "Ovid and Takeda are sharing 50/50 in the drug development",
    "percentageofnetexpensesofdevelopmentcostsrecordedinresearchanddevelopment": 0.5,
    "cashfdicinsuredamount": 250000,
    "availableforsalesecuritiesinvestmentsmaturityperiod": "P3M",
    "propertyplantandequipmentestimatedusefullives": "Property and equipment are stated at cost and depreciated over their estimated useful lives of three years using the straight-line method.",
    "propertyplantandequipmentusefullife": "P3Y",
    "assetsfairvaluedisclosure": 70100000,
    "definedcontributionplanname": "401(k)-retirement plan",
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.5,
    "definedcontributionplanemployermatchingcontributionpercent": 0.05,
    "definedcontributionplanemployerdiscretionarycontributionamount": 321000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 3250,
    "cashequivalentsatcarryingvalue": 72033930,
    "cashandcashequivalentsfairvaluedisclosure": 72033930,
    "propertyplantandequipmentgross": 320957,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 185337,
    "depreciation": 60000,
    "finitelivedintangibleassetsnet": 319000,
    "amortizationofintangibleassets": 247000,
    "clinicaltrialsaccrualcurrent": 4175497,
    "employeerelatedliabilitiescurrent": 3845441,
    "accruedprofessionalfeescurrent": 3846211,
    "otheraccruedliabilitiescurrent": 165536,
    "commonstockvotingrights": "one vote for each share held",
    "convertiblepreferredstocksharesissueduponconversion": 1000,
    "maximumallowableowningpercentageofoutstandingcommonstockbyassociatesoraffiliates": 0.0999,
    "maximumallowablevotingrightpercentageofoutstandingcommonstockholders": 0.1499,
    "convertiblepreferredstocktermsofconversion": "percentage may be changed at the holder’s election to any other number less than or equal to 19.99% upon 61 days’ notice to the Company; provided, however, that effective 61 days after delivery of such notice, such beneficial ownership limitations shall not be applicable to any holder that beneficially owns either 10.0% or 15.0%",
    "preferredstockliquidationpreference": 0.001,
    "dividendpaymentrestrictionsscheduledescription": "No dividends on the common stock shall be declared and paid unless dividends on the Preferred Stock have been declared and paid.",
    "commonstockcapitalsharesreservedforfutureissuance": 279069,
    "sharebasedcompensationarrangementbysharebasedpaymentawardplanmodificationdescriptionandterms": "The number of shares of common stock reserved for issuance under the 2017 ESPP will automatically increase on January 1 of each year, beginning on January 1, 2018 and continuing through and including January 1, 2027, by the lesser of (i) 1% of the total number of shares of the Company’s capital stock outstanding on December 31 of the preceding calendar year, (ii) 550,000 shares or (iii) such lesser number of shares determined by our Board.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 553552,
    "initialofferingperiod": "On September 20, 2017, the Company’s Compensation Committee approved an offering period under the 2017 ESPP, which began on October 20, 2017.",
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpricepurchasedate": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharespurchasedforaward": 105464,
    "allocatedsharebasedcompensationexpense": 152973,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumnumberofsharesperemployee": 550000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P90D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 4975262,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 3583160,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 12300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y14D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.7437,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y7M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0232,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 10403420,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 5395658,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 415526,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 5.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 6.45,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.93,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.82,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y7M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P6Y1M17D",
    "sharebasedcompensationbysharebasedpaymentawardoptionsgrantedcontractuallife": "P9Y8M4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 652438,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 445599,
    "operatinglosscarryforwards": 165400000,
    "operatinglosscarryforwardsexpirationperiodstart": 2035,
    "valuationallowancedeferredtaxassetchangeinamount": 13300000,
    "deferredtaxassetsoperatinglosscarryforwards": 74064673,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 5458004,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 4978370,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitsemployeecompensation": 514316,
    "deferredtaxliabilitiespropertyplantandequipment": 29760,
    "deferredtaxassetscharitablecontributioncarryforwards": 87120,
    "deferredtaxassetsgoodwillandintangibleassets": 4742031,
    "deferredtaxassetsgross": 89814754,
    "deferredtaxassetsvaluationallowance": 89814754,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0615,
    "effectiveincometaxratereconciliationnondeductibleexpense": 0.0075,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.1672,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.0264,
    "effectiveincometaxratereconciliationotheradjustments": 0.0002,
    "deferredincometaxexpensebenefit": 5800000,
    "licenseagreementupfrontpayment": 25000000,
    "aggregatelicenseagreementmilestonepayments": 55000000,
    "salesmilestonepaymentsthroughlicenseagreement": 162500000,
    "potentialfundingcostpercent": 0.35,
    "costofagreementnet": 7000000,
    "deferredupfrontpaymentcosts": 7000000,
    "upfrontfeeamount": 20000000,
    "amountforpotentialfuturetrials": 7000000,
    "aggregatetechtransferandregulatorypaymentsthroughlicenseagreement": 5000000,
    "additionaltechtransferthroughlicenseagreement": 5000000,
    "additionalaggregatetechtransferandregulatorypaymentsthroughlicenseagreement": 55000000,
    "licenserevenue": 6100000,
    "incomefromongoingtrials": 1500000,
    "incomefromtransferofspecifiedamountofcompoundandrelatedinformation": 5000000,
    "deferredrevenue": 12400000,
    "relatedpartytransactiontermsandmannerofsettlement": "any time and for any reason, upon thirty (30) days written notice to the other party."
  },
  {
    "date": "2019-12-30",
    "symbol": "OVID",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Ovid Therapeutics Inc.",
    "entitycentralindexkey": 1636651,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Accelerated Filer",
    "entityinteractivedatacurrent": "Yes",
    "entityextransitionperiod": "true",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "OVID",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-38085",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "46-5270895",
    "entityaddressaddressline1": "1460 Broadway",
    "entityaddressaddressline2": "Suite 15044",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10036,
    "cityareacode": 646,
    "localphonenumber": "661-7661",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 41897144,
    "availableforsalesecuritiesdebtsecuritiescurrent": 34841969,
    "accountsreceivablerelatedparties": 1131146,
    "prepaidexpenseandotherassetscurrent": 1942933,
    "assetscurrent": 79813192,
    "prepaidexpensenoncurrent": 359539,
    "securitydeposit": 135390,
    "propertyplantandequipmentnet": 68363,
    "otherassetsnoncurrent": 467247,
    "assets": 80843731,
    "accountspayablecurrent": 3256098,
    "accruedliabilitiescurrent": 7266706,
    "duetorelatedpartiescurrent": 10804,
    "liabilitiescurrent": 10533608,
    "duetorelatedpartiesnoncurrent": 286562,
    "liabilities": 10820170,
    "preferredstockvalue": 8,
    "commonstockvalue": 54711,
    "additionalpaidincapitalcommonstock": 283122894,
    "accumulatedothercomprehensiveincomelossnetoftax": 2469,
    "retainedearningsaccumulateddeficit": -213156521,
    "stockholdersequity": -213156521,
    "liabilitiesandstockholdersequity": 80843731,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "preferredstocksharedesignated": 10000,
    "preferredstocksharesissued": 7762,
    "preferredstocksharesoutstanding": 7762,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 125000000,
    "commonstocksharesissued": 54710322,
    "commonstocksharesoutstanding": 54710322,
    "researchanddevelopmentexpense": 4707940,
    "generalandadministrativeexpense": 19251826,
    "operatingexpenses": 61409467,
    "operatingincomeloss": -61409467,
    "nonoperatingincomeexpense": 948224,
    "netincomeloss": -60461243,
    "netincomelossavailabletocommonstockholdersbasic": -60461243,
    "earningspersharebasicanddiluted": -1.54,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 39217223,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 4298,
    "comprehensiveincomenetoftax": -60456945,
    "sharesissued": 54710322,
    "stockissuedduringperiodvaluenewissues": 22286566,
    "stockissuedduringperiodsharesnewissues": 6893888,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 131895,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 80542,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 1261,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": -1262000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 5205792,
    "othercomprehensiveincomelossnetoftax": 4298,
    "sharebasedcompensation": 5205792,
    "depreciationdepletionandamortization": 255002,
    "accruedinterestandaccretionofdiscountsshortterminvestments": -29633,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -224458,
    "increasedecreaseinsecuritydeposits": -13235,
    "increasedecreaseduefromaffiliates": 531042,
    "increasedecreaseinprepaidexpensenoncurrent": -2438022,
    "increasedecreaseinaccountspayabletrade": -653953,
    "increasedecreaseinaccruedliabilities": 2177844,
    "increasedecreaseinduetorelatedparties": 297366,
    "netcashprovidedbyusedinoperatingactivities": -51090622,
    "paymentstoacquireavailableforsalesecuritiesdebt": 34797004,
    "proceedsfrommaturitiesprepaymentsandcallsofavailableforsalesecurities": 5000000,
    "paymentstoacquirepropertyplantandequipment": 57156,
    "paymentstodevelopsoftware": 186889,
    "netcashprovidedbyusedininvestingactivities": -30041049,
    "proceedsfromissuanceofcommonstock": 22286566,
    "proceedsfromstockplans": 131895,
    "netcashprovidedbyusedinfinancingactivities": 86539197,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 5407526,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 41897144,
    "noninterestexpenseofferingcost": 69628,
    "softwaredevelopmentandothercostsinaccountspayableandaccruedexpenses": 164922,
    "cashcashequivalentsandshortterminvestments": 76700000,
    "descriptionofownershippatternasperlicenseandcollaborationagreement": "Ovid and Takeda are sharing 50/50 in the drug development and throughout the life of this compound",
    "percentageofnetexpensesofdevelopmentcostsrecordedinresearchanddevelopment": 0.5,
    "cashfdicinsuredamount": 250000,
    "availableforsalesecuritiesinvestmentsmaturityperiod": "P3M",
    "propertyplantandequipmentestimatedusefullives": "Property and equipment are stated at cost and depreciated over their estimated useful lives of three years using the straight-line method.",
    "propertyplantandequipmentusefullife": "P3Y",
    "assetsfairvaluedisclosure": 76200000,
    "definedcontributionplanplanname": "401(k)-retirement plan",
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.5,
    "definedcontributionplanemployermatchingcontributionpercent": 0.05,
    "definedcontributionplanemployerdiscretionarycontributionamount": 285000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7762,
    "cashequivalentsatcarryingvalue": 41897144,
    "cashandcashequivalentsfairvaluedisclosure": 41897144,
    "availableforsaledebtsecuritiesamortizedcostbasis": 34839500,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 2469,
    "debtsecuritiesavailableforsalecontinuousunrealizedgainpositionlessthan12months": 34800000,
    "propertyplantandequipmentgross": 193717,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 125354,
    "depreciation": 39000,
    "finitelivedintangibleassetsnet": 467000,
    "amortizationofintangibleassets": 216000,
    "clinicaltrialsaccrualcurrent": 3235527,
    "employeerelatedliabilitiescurrent": 2728495,
    "accruedprofessionalfeescurrent": 1070589,
    "otheraccruedliabilitiescurrent": 232095,
    "commonstockvotingrights": "one vote for each share held",
    "proceedsfromissuanceorsaleofequity": 22300000,
    "convertiblepreferredstocksharesissueduponconversion": 1000,
    "maximumallowableowningpercentageofoutstandingcommonstockbyassociatesoraffiliates": 0.0999,
    "maximumallowablevotingrightpercentageofoutstandingcommonstockholders": 0.1499,
    "convertiblepreferredstocktermsofconversion": "percentage may be changed at the holder’s election to any other number less than or equal to 19.99% upon 61 days’ notice to the Company; provided, however, that effective 61 days after delivery of such notice, such beneficial ownership limitations shall not be applicable to any holder that beneficially owns either 10.0% or 15.0%",
    "preferredstockliquidationpreference": 0.001,
    "dividendpaymentrestrictionsscheduledescription": "No dividends on the common stock shall be declared and paid unless dividends on the Preferred Stock have been declared and paid.",
    "commonstockcapitalsharesreservedforfutureissuance": 279069,
    "sharebasedcompensationarrangementbysharebasedpaymentawardplanmodificationdescriptionandterms": "The number of shares of common stock reserved for issuance under the 2017 ESPP will automatically increase on January 1 of each year, beginning on January 1, 2018 and continuing through and including January 1, 2027, by the lesser of (i) 1% of the total number of shares of the Company’s capital stock outstanding on December 31 of the preceding calendar year, (ii) 550,000 shares or (iii) such lesser number of shares determined by our Board.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 659016,
    "initialofferingperiod": "On September 20, 2017, the Company’s Compensation Committee approved an offering period under the 2017 ESPP, which began on October 20, 2017.",
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpricepurchasedate": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharespurchasedforaward": 80542,
    "allocatedsharebasedcompensationexpense": 109319,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumnumberofsharesperemployee": 550000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P90D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 3963544,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 3547513,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 9837812,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y7M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.7456,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0237,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7405295,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 3296547,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 856601,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 5.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 7.93,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.93,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 6.43,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y3D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P6Y6M10D",
    "sharebasedcompensationbysharebasedpaymentawardoptionsgrantedcontractuallife": "P9Y6M21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 4488930,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 356443,
    "operatinglosscarryforwards": 163000000,
    "operatinglosscarryforwardsexpirationperiodstart": 2035,
    "valuationallowancedeferredtaxassetchangeinamount": 22467000,
    "deferredtaxassetsvaluationallowance": 76463170,
    "deferredtaxassetsoperatinglosscarryforwards": 57288334,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 3351315,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 6606889,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitsemployeecompensation": 898067,
    "deferredtaxliabilitiespropertyplantandequipment": 22026,
    "deferredtaxassetscharitablecontributioncarryforwards": 132072,
    "deferredtaxassetsgoodwillandintangibleassets": 8208519,
    "deferredtaxassetsgross": 76463170,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.138,
    "effectiveincometaxratereconciliationnondeductibleexpense": 0.005,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.3714,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.0267,
    "effectiveincometaxratereconciliationotheradjustments": -0.0017,
    "relatedpartytransactiontermsandmannerofsettlement": "any time and for any reason, upon thirty (30) days written notice to the other party."
  }
]